FindTrial
Sign In

outcomes of Head and neck cancer in HIV and Hepatitis B & C patients.

Head and neck squamous cell carcinoma in seropositive patients-prognosis and its predictors.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/012911
Enrollment
100
Registered
2018-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Seropositive (HIV, HbsAg, HCV positive, either any one or more than one)Head and Neck Squamous Cell Carcinoma patients.

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between >18 yrs. 2. Patient with HNSCC(all stages) treated at TMH. 3.Treatment Naïve.

Exclusion criteria

Exclusion criteria: Second primary/Recurrence

Design outcomes

Primary

MeasureTime frame
To determine difference in overall survival and disease free survival between the two groups.Timepoint: At the end of the study—

Secondary

MeasureTime frame
1.To study the difference in clinical presentation, if any. 2. To find any relationship between CD4 counts in HIV positive patients before the start of treatment and its correlation with prognosis. Timepoint: At the end of the study—

Countries

India

Contacts

Public ContactShivakumar Thiagarajan

Tata Memorial Hospital, Mumbai

drshiva78in@gmail.com02224176656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026